713-928-2355
Menu
  • Home
  • Practice Areas
    • Personal Injury and Dangerous Devices
      • Philips® CPAP Recall
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • 3M Earplug Lawsuit
    • Drug Injury
      • Purdue Opioid Claim
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Shingles Vaccine Lawsuit Zostavax®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
  • Maritime Injury
  • Buffalo Bayou or SJ River Claim
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
  • Home

Bleeding in Spinal Column from Lovenox Use: FDA Update

The U.S. Food and Drug Administration (FDA) released a Safety Announcement including updated recommendations to decrease risk of spinal column bleeding and paralysis in patients on low molecular weight haprins. The agency is recommending...
  • More
  • 0
  • 0
  • 0
Posted November 6, 2013 | by victorlongo |in Uncategorized

Class 1 Recall on Bard LifeStent Solo Vascular Stent

The FDA has issued safety information regarding a Class 1 recall of Bard LifeStent Solo Vascular Stent.  The product has been recalled due to deployment issues that range from failure to deploy, partial deployment, and difficult deployment.  The...
  • More
  • 0
  • 0
  • 0
Posted October 18, 2013 | by victorlongo |in Uncategorized

Antidepressants and Diabetes Linked in University Study

Researchers at the University of Southampton have warned that some antidepressants may pose a risk of type 2 diabetes.  A systematic review carried out by the University showed a higher risk of type 2 diabetes in people taking antibiotics...
  • More
  • 0
  • 0
  • 0
Posted September 30, 2013 | by victorlongo |in Uncategorized

Gilenya Safety Alert

Gilenya and PML The U.S. Food and Drug Administration (FDA) has issued a drug safety communication regarding Gilenya, a drug the agency believes might be associated with a rare brain infection. The FDA reported that a patient in Europe who was...
  • More
  • 0
  • 0
  • 0
Posted September 1, 2013 | by victorlongo |in Uncategorized

Levaquin, Cipro, and More Required to Update Drug Labels and Medication Guides

The U.S. Food and Drug Administration (FDA) issued a safety alert stating that all fluoroquinolone antibacterial drugs must have updated drug labels and Medication Guides. List of Fluoroquinolone Drug Products The information currently missing...
  • More
  • 0
  • 0
  • 0
Posted August 16, 2013 | by victorlongo |in Uncategorized

FDA Warns of Rare Skin Reactions Associated with Acetaminophen

FDA Acetaminophen Warning The U.S. Food and Drug Administration released a Safety Communication warning that acetaminophen has been associated with the risk of a serious skin reaction.  The reaction, known as Stevens-Johnson Syndrome (SJS), toxic...
  • More
  • 0
  • 0
  • 0
Posted August 2, 2013 | by victorlongo

FDA Limits Usage of Nizoral Due to Liver Injury, Drug Interactions, and Adrenal Gland Problems

FDA Nizoral Safety Communication   The U.S. Food and Drug Administration issued a Drug Safety Communication describing new actions they are taking related to Nizoral oral tablets.  The agency warns that the drug can cause severe liver...
  • More
  • 0
  • 0
  • 0
Posted July 27, 2013 | by victorlongo |in Uncategorized

Monster Energy Sued After Teen’s Death

A lawsuit filed Tuesday blames Monster energy drinks for the death of a California teen.  The mother of the teenager who died from cardiac arrhythmia last year is blaming her son’s death on Monster Beverage, according to the lawsuit. Alex...
  • More
  • 0
  • 0
  • 0
Posted July 1, 2013 | by victorlongo |in Uncategorized

Prolia Side Effects May Increase Risk of Low Trauma Fractures

In a recent addition of Public Citizen’s Worst Pills, Best Pills Newsletter, the consumer watchdog group warns that the Amgen bone drug Prolia may increase the risk of sudden bone fractures.  The fractures may occur with little, or even no...
  • More
  • 0
  • 0
  • 0
Posted June 10, 2013 | by victorlongo

FDA Samsca Warning: Potential Risk of Liver Injury

The U.S. Food and Drug Administration released a Safety Announcement stating that the drug Samsca should not be used for longer than 30 days.  The announcement also said that the drug should not be used in patients with underlying liver disease...
  • More
  • 0
  • 0
  • 0
Posted June 5, 2013 | by victorlongo |in Uncategorized

Pharmaceutical Company Recalls Sterile Compounded Products

The following is a Press Release from Lowlite Investments d/b/a Olympia Pharmacy (“Lowlite”) FOR IMMEDIATE RELEASE – May 29, 2013 – Lowlite Investments d/b/a Olympia Pharmacy (“Lowlite”) today announced a voluntary multi-state...
  • More
  • 0
  • 0
  • 0
Posted May 30, 2013 | by victorlongo |in Uncategorized

FDA Links Samsca to Liver Injury

In a recent Safety Announcement, the U.S. Food and Drug Administration (FDA) announced that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can...
  • More
  • 0
  • 0
  • 0
Posted May 1, 2013 | by victorlongo |in Uncategorized
  • « First
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • Next »
  • Last »

LikeBox

Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal